Institute of Biomedical Research Corp.
MRES · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 106.3% | 20.9% | -41.4% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 47.4% | 22.1% | 35.8% | 56.5% |
| R&D Expenses | -$0 | -$0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | -$0 | $0 | $0 |
| Operating Income | -$0 | $0 | -$0 | -$0 |
| % Margin | -1,509.9% | 1,590.3% | -3,236.8% | -2,764.4% |
| Other Income/Exp. Net | -$0 | -$0 | $0 | -$0 |
| Pre-Tax Income | -$0 | $0 | -$0 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | $0 | -$0 | -$0 |
| % Margin | -753.8% | 1,698.6% | -2,536.7% | -3,417% |
| EPS | -0 | 0 | -0 | -0 |
| % Growth | -200% | 200% | 50% | – |
| EPS Diluted | -0 | 0 | -0 | -0 |
| Weighted Avg Shares Out | 2,664 | 2,371 | 2,371 | 2,371 |
| Weighted Avg Shares Out Dil | 2,664 | 2,371 | 2,371 | 2,371 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | $0 | -$0 | -$0 |
| % Margin | -1,569.6% | 1,496.4% | -2,140.5% | -3,054.7% |